Ayahuasca or esketamine: One-Dose PTSD trial launches
NCT ID NCT07317206
First seen Jan 05, 2026 · Last updated May 12, 2026 · Updated 18 times
Summary
This study tests whether a single dose of ayahuasca or esketamine can ease symptoms of posttraumatic stress disorder (PTSD). Ten adults with PTSD will receive one of the two treatments in a double-blind, randomized setup. The goal is to see if either drug reduces PTSD symptoms quickly and safely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTTRAUMATIC STRESS DISORDER (PTSD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital das Clínicas da FMRP-USP
RECRUITINGRibeirão Preto, São Paulo, 14049900, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.